Resonance Specialties Limited reported a sharp 252% year-on-year surge in net profit to ₹574.42 lakhs for the quarter ended June 30, 2026, driven primarily by a doubling of international revenues. The Board of Directors, meeting on August 4, 2026, approved the unaudited financial results and simultaneously greenlit the acquisition of a strategic manufacturing facility in Madhya Pradesh for ₹29.98 crores. This dual announcement signals both strong operational performance and aggressive capacity expansion through vertical integration.

Financial Performance Highlights

Revenue from operations rose to ₹3,258.41 lakhs in Q1FY27, up from ₹2,127.42 lakhs in the corresponding period of FY26. Total income stood at ₹3,312.19 lakhs, including other income of ₹53.78 lakhs. Profit before tax jumped to ₹764.93 lakhs from ₹237.24 lakhs year-ago. The company’s basic and diluted earnings per share (EPS) were ₹4.98 each, compared to ₹1.41 in Q1FY26.

Expense Management and Margins

Total expenses increased to ₹2,547.26 lakhs from ₹1,912.89 lakhs, reflecting higher input costs associated with increased production volumes. Key expense components included cost of materials consumed at ₹1,360.36 lakhs and conversion charges at ₹332.13 lakhs. Employee benefits expense rose to ₹161.93 lakhs from ₹141.96 lakhs. Finance costs remained negligible at ₹1.27 lakhs. The expansion in revenue outpaced the rise in expenses, leading to improved operating leverage.

Export-Led Growth

The primary driver of the financial performance was robust international demand. Revenue from outside India more than doubled to ₹2,326.08 lakhs from ₹1,065.49 lakhs in Q1FY26, accounting for approximately 71% of total revenue. Domestic revenue from India declined slightly to ₹932.33 lakhs from ₹1,061.93 lakhs. This shift underscores the company’s growing reliance on global markets for specialty chemicals and APIs.

Acquisition of Mandideep Facility

In a significant strategic move, Resonance Specialties approved the purchase of a manufacturing facility at Plot No. 6, New Industrial Area-II, Mandideep, Madhya Pradesh, from Kaygee Laboratories Private Limited (KLPL), a promoter group entity. The transaction, valued at ₹29.98 crores on a slump sale basis, includes leasehold land of 22,304 sq. mtrs., industrial buildings of 5,227 sq. mtrs., plant machinery, licenses, and employees.

The facility, originally set up in 1990, has been supplying chemical intermediates and APIs to Resonance Specialties on a job work basis. It was recently inspected and approved by WHO, Geneva. The acquisition aims to secure uninterrupted production, enhance operational control, and eliminate outsourcing costs. Shareholder approval is required for the transaction, which is expected to be completed by November 30, 2026. The deal is structured as an arm’s length related party transaction based on an independent valuer’s certificate.

Auditor’s Review and Compliance

The unaudited financial results were reviewed by Kailash Chand Jain & Co., Chartered Accountants, who issued a limited review report pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The auditors noted no material misstatements. The results were prepared in accordance with Ind AS-34 and reviewed by the audit committee before Board approval. As of June 30, 2026, the company has no subsidiaries, associates, or joint ventures.

Source: https://lodr-files.dhan.co/lodr-inputs/Company/INE486D01017/1e4cca1b-2470-47b7-87cc-73573d40d388.pdf

Resonance Specialties Limited has fixed Tuesday, July 28, 2026, as the record date to determine member eligibility for a dividend of Re 1 per share. The dividend, equivalent to 10% of the face value of ₹10 each, is subject to approval at the company's ensuing 37th Annual General Meeting (AGM). If sanctioned, the payout will be made on or before August 28, 2026.

The company's 37th AGM is scheduled for Tuesday, August 4, 2026, at 12:30 p.m. via video conferencing. The meeting will be conducted in compliance with the Companies Act, 2013, and SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Members attending through video conferencing will be reckoned for the purpose of quorum under Section 103 of the Act.

The Notice of the AGM and the Financial Statements for the Financial Year 2025-26, along with the Board of Directors' and Auditors' reports, will be sent exclusively by email to members whose email addresses are registered with the company, the Registrar and Share Transfer Agent (RTA), or Depository Participants. These documents will also be available on the company's website, the BSE Limited website, and the National Securities Depository Limited (NSDL) website.

The company has provided an electronic voting facility for members to exercise their rights on the agenda items. E-voting services will be provided by NSDL, and members can also vote during the AGM. Members holding shares in physical mode must send an email to the company or the RTA with their registered Folio Number, email address, self-attested PAN card, address proof, contact number, and bank account details to receive annual reports and dividends.